Cost Minimization Analysis and Budget Impact Model of Treatment of Chronic Hepatitis C Virus with Grazoprevir (Gzr, Mk - 5172 / Elbasvir (Ebr, Mk - 8742) in Patients with Genotypes 1 and 4 in Mexico
Abstract
Authors
N Chizoba H Monsanto A Mondragon E Varela K Rely C Perez Bolde-Villarreal